These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 10435620
1. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome. Quesnel S, Verselis S, Portwine C, Garber J, White M, Feunteun J, Malkin D, Li FP. Oncogene; 1999 Jul 08; 18(27):3970-8. PubMed ID: 10435620 [Abstract] [Full Text] [Related]
3. [Germline mutations of the p53 gene]. Frebourg T. Pathol Biol (Paris); 1997 Dec 08; 45(10):845-51. PubMed ID: 9769948 [Abstract] [Full Text] [Related]
4. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family. Plummer SJ, Santibáñez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H, Casey G. Oncogene; 1994 Nov 08; 9(11):3273-80. PubMed ID: 7936651 [Abstract] [Full Text] [Related]
5. Cancer risks from germ line tumor suppressor gene mutations. Frebourg T, Malkin D, Friend S. Princess Takamatsu Symp; 1991 Nov 08; 22():61-70. PubMed ID: 1844252 [Abstract] [Full Text] [Related]
6. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family. Stolzenberg MC, Brugières L, Gardes M, Dessarps-Freichey F, Chompret A, Bressac B, Lenoir G, Bonaïti-Pellié C, Lemerle J, Feunteun J. Oncogene; 1994 Oct 08; 9(10):2799-804. PubMed ID: 8084585 [Abstract] [Full Text] [Related]
7. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL. Oncogene; 2001 Jul 27; 20(33):4441-9. PubMed ID: 11494139 [Abstract] [Full Text] [Related]
8. [Li-Fraumeni syndrome and germ-line mutations of the p53 gene]. Leblanc T, Soussi T. Arch Pediatr; 1994 Jan 27; 1(1):61-70. PubMed ID: 8087224 [Abstract] [Full Text] [Related]
10. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies. Pötzsch C, Voigtländer T, Lübbert M. J Cancer Res Clin Oncol; 2002 Aug 27; 128(8):456-60. PubMed ID: 12200603 [Abstract] [Full Text] [Related]
14. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA. Cancer Res; 2003 Oct 15; 63(20):6643-50. PubMed ID: 14583457 [Abstract] [Full Text] [Related]
18. Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: a review. Soussi T, Leblanc T, Baruchel A, Schaison G. Nouv Rev Fr Hematol (1978); 1993 Feb 15; 35(1):33-6. PubMed ID: 8511038 [Abstract] [Full Text] [Related]
19. The Li-Fraumeni syndrome: an inherited susceptibility to cancer. Evans SC, Lozano G. Mol Med Today; 1997 Sep 15; 3(9):390-5. PubMed ID: 9302689 [Abstract] [Full Text] [Related]
20. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Achatz MI, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM, Ashton-Prolla P, Giugliani R, Palmero EI, Vargas FR, Da Rocha JC, Vettore AL, Hainaut P. Cancer Lett; 2007 Jan 08; 245(1-2):96-102. PubMed ID: 16494995 [Abstract] [Full Text] [Related] Page: [Next] [New Search]